Skip to content
Medical Health Aged Care

AmblyoPlay Launches New Technology for Greater Peripheral Vision Stimulation

AmblyoPlay 2 mins read

Idrija, Slovenia / October 16, 2024 - AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch of its revolutionary technology: Active Peripheral Stimulation (APS). APS, which is intended to advance the treatment of peripheral vision deficiencies, is a significant step towards improving the effectiveness of home-based vision therapy.

 

APS technology, available within the existing AmblyoPlay Vision Therapy, is tailored to improve peripheral vision by actively engaging and stimulating the peripheral areas of the retina. This unique approach improves the brain’s ability to integrate peripheral inputs, resulting in increased spatial awareness.

While amblyopia (often referred to as ‘lazy eye’) may sound like a very niche problem, up to 5% of the population suffer from this vision disorder worldwide. Nonetheless, it remains a substantial global vision problem, and public health initiatives of early screening, treatment, and management are critical.

 

Normal versus amblyopic eye.

Normal versus amblyopic eye.

 

People with amblyopia and other binocular vision problems often struggle with depth perception, hand-eye coordination, and reading difficulties and may experience frustration or lower self-esteem due to challenges in everyday tasks like driving, sports, and learning.

 

AmblyoPlay raises the bar for treating amblyopia, strabismus, convergence insufficiency, and other visual impairments by incorporating APS technology within vision therapy. The technology has been seamlessly incorporated into therapeutic exercises, ensuring a smooth and engaging experience for users of all ages.

 

“With APS, we’re expanding the boundaries of what vision therapy can achieve,” said Matic Vogrič, CEO of AmblyoPlay.

 

About AmblyoPlay Vision Therapy

 

AmblyoPlay was born from conversations with doctors and parents, all facing a common challenge: how to keep young patients motivated during vision therapy homework. Existing solutions were repetitive and disengaging, leading to frustration. Therefore, AmblyoPlay transformed vision therapy into a gamified experience—turning a routine task into something fun. 

This playful approach not only keeps patients engaged but also improves adherence to therapy, helping families and doctors work together toward better vision outcomes.

AmblyoPlay is a vision therapy solution designed to treat vision impairments such as amblyopia (lazy eye), strabismus (crossed eyes), convergence insufficiency, double vision, and other binocular vision disorders. It complements in-clinic vision therapy and increases at-home vision therapy adherence through gamification.

 

By offering personalized and evidence-based therapy, AmblyoPlay provides effective solutions for children and adults alike, bringing engaging therapy into the comfort of users’ homes.

 

Until now, it has helped more than 25,000 users worldwide. Discover more about AmblyoPlay at https://amblyoplay.com/ or watch the video.

Discover more about AmblyoPlay

 


Contact details:

Contact Information:

Matic Vogrič, CEO
AmblyoPlay
matic.vogric@amblyoplay.com

 

 

 

Media

More from this category

  • Medical Health Aged Care, Women
  • 11/02/2025
  • 07:10
Breast Cancer Network Australia

Australian women denied knowledge of BREAST DENSITY and their increased breast cancer risk

11th February 2025 Fact: Approximately 10% of women have high breast density, which significantly increases the risk of developing breast cancer and impacts the effectiveness of detecting breast cancer through 2D mammography. Despite this, thousands of Australian women are being denied this important information due to the absence of national reporting standards and a lack of software in publicly funded screening services that can effectively measure breast density. Western Australia and South Australia routinely notify women of their breast density. Queensland is currently conducting trials, Victoria is expected to report breast density to all clients by early 2025 and New…

  • Medical Health Aged Care
  • 11/02/2025
  • 06:05
Royal Australian College of GPs

RACGP launches plan for more GPs and lower fees: to halve out-of-pocket costs, increase bulk billing

The Royal Australian College of GPs is urging all political parties to support its plan to ensure access to affordable GP care for everyone in Australia. The plan will halve out-of-pocket costs, deliver 6.2 million more bulk billed consults each year, and get more specialist GPs training in communities. Australia’s peak body for general practice and GP training with over 50,000 members, the RACGP is launching its plan for accessible and affordable GP care at Parliament House today. Independently verified analysis shows it will: get the bulk billing rate back to 85% for those who need it most, creating 6.2…

  • Medical Health Aged Care
  • 11/02/2025
  • 01:11
AGFA HealthCare

An Incredible KLAS Triple-Award Win for AGFA HealthCare!

MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product for 2025."To receive a KLAS Award is one of the most notable wins for AGFA HealthCare, and a testament to the hard work we invest into our flagship platform. More importantly, it reflects the trust and recognition from our customers. Their success is our success, and to receive two such awards is simply breathtaking." - Nathalie McCaughley, President, AGFA HealthCareThe Best in KLAS…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.